Enovix said CEO Raj Talluri resigned on Aug. 13 to pursue what Executive Chairman T.J. Rodgers described as a dream job, prompting the board a day later to accept his resignation, appoint CFO Ryan Benton as Interim CEO, appoint Rodgers as Executive Chairman and begin a search evaluating both internal and external candidates. The company framed the move as a leadership transition rather than a strategy shift, saying its smartphone qualification work, smart eyewear ramp, defense and drone programs, customer schedules, operating leadership in Malaysia and Korea, and third-quarter 2026 guidance remain unchanged. In an investor webcast summary, Enovix highlighted its management bench and gave a fuller look at its operating structure. Benton joined as CFO in April 2025 and previously moved from CFO to CEO at Exar. COO Michael Vyvoda, who joined in July 2026, oversees manufacturing, supply chain and equipment engineering across both factories. Chief Business Officer Samira Naraghi helped define and launch the company’s first smartphone-grade battery with Honor, while Jonathan Doan, SVP of R&D, has led development across every generation of the battery platform. Ed Casey, VP of Operations, leads advanced manufacturing engineering, and Kihong "KH" Park, SVP of Global Manufacturing Operations, runs the Korean and Penang plants. The company also provided more detail on its battery technology and commercial targets. Enovix said its silicon-carbon composite anode and optimized electrolyte now support 1,000 charging cycles, compared with early versions that lasted as few as 10 cycles, and said its lead smartphone customer confirmed more than 1,000 cycles last quarter. For smartphones, Enovix is targeting final cycle-life testing in 2026 and qualification samples to a second OEM in the fourth quarter of 2026. In smart eyewear, it said a first 50,000-unit order is now shipping, with about 19,000 units expected to ship in the third quarter. In drones and defense, it said its pipeline reached $183 million, up 41% in the second quarter of 2026, while Korean capacity is expanding from $40 million to $100 million. Enovix reaffirmed Q3 2026 guidance for revenue of $9 million to $10 million, non-GAAP operating loss of $29 million to $32 million, non-GAAP net loss per share of $0.13 to $0.17, and capital expenditures of $8 million to $12 million, with about $552.1 million in cash, cash equivalents and marketable securities, including restricted cash, at the end of Q2 2026.